$113 Million is the total value of Defender Capital, LLC.'s 19 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 5.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKB | Sell | BERKSHIRE HATHAWAY | $25,651,000 | +0.8% | 113,252 | -7.5% | 22.78% | +0.9% |
| STAA | Buy | STAAR SURGICAL CORPORATION | $21,188,000 | +40.5% | 602,453 | +3.1% | 18.82% | +40.7% |
| MNST | Buy | MONSTER BEVERAGE CORPORATION | $19,447,000 | +20.0% | 306,010 | +9.5% | 17.27% | +20.1% |
| FTV | Buy | FORTIVE CORPORATION | $16,088,000 | +15.6% | 210,605 | +3.8% | 14.29% | +15.8% |
| CFX | Sell | COLFAX CORPORATION | $6,150,000 | +19.2% | 169,043 | -4.9% | 5.46% | +19.3% |
| WINA | Sell | WINMARK CORPORATION | $3,696,000 | +8.1% | 18,636 | -3.9% | 3.28% | +8.2% |
| AXON | New | AXON ENTERPRISE INC | $3,568,000 | – | 48,695 | +100.0% | 3.17% | – |
| LCTX | Buy | LINEAGE CELL THERAPEUTIC | $3,540,000 | -4.6% | 3,977,045 | +4.8% | 3.14% | -4.5% |
| VGSH | Buy | VANGUARD SHORT TERM TREASURY ETFetf | $2,981,000 | +6.4% | 49,000 | +6.5% | 2.65% | +6.5% |
| KMI | Buy | KINDER MORGAN INC | $2,500,000 | +2.8% | 118,089 | +0.2% | 2.22% | +3.0% |
| DHR | Sell | DANAHER CORPORATION | $2,129,000 | -89.4% | 138,772 | -0.8% | 1.89% | -89.4% |
| INO | Sell | INOVIO PHARMA | $1,884,000 | +47.3% | 570,800 | -8.3% | 1.67% | +47.4% |
| CGEN | Buy | COMPUGEN LIMITED | $1,814,000 | +44.3% | 304,333 | +2.4% | 1.61% | +44.5% |
| AAPL | Buy | APPLE INC | $696,000 | +32.8% | 2,371 | +0.7% | 0.62% | +32.9% |
| AMZN | Buy | AMAZON.COM INC | $453,000 | +6.8% | 245 | +0.4% | 0.40% | +6.9% |
| AGE | Sell | AGEX THERAPEUTICS INC | $251,000 | -38.3% | 138,192 | -32.6% | 0.22% | -38.2% |
| MSFT | MICROSOFT CORPORATION | $240,000 | +13.7% | 1,520 | 0.0% | 0.21% | +13.9% | |
| CSCO | CISCO SYSTEMS INC | $208,000 | -3.3% | 4,349 | 0.0% | 0.18% | -3.1% | |
| FIT | FITBIT INC | $131,000 | +72.4% | 20,000 | 0.0% | 0.12% | +73.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL CL B | 20 | Q3 2023 | 24.4% |
| DANAHER CORPORATION COM | 20 | Q3 2023 | 18.3% |
| STAAR SURGICAL CORPORATION | 20 | Q3 2023 | 20.2% |
| FORTIVE CORPORATION | 20 | Q3 2023 | 14.3% |
| MONSTER BEVERAGE CORPORATION | 20 | Q3 2023 | 17.3% |
| APPLE INC | 20 | Q3 2023 | 0.6% |
| AMAZON INC COM | 20 | Q3 2023 | 0.4% |
| VANGUARD SHORT TERM TREASURY ETF IV | 17 | Q3 2023 | 23.9% |
| LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 4.8% |
| COMPUGEN LTD ORD | 17 | Q1 2023 | 1.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-23 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-07-18 |
| 13F-HR/A | 2023-05-16 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-12 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-07-26 |
| 13F-HR/A | 2022-06-07 |
| 13F-HR | 2022-04-22 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.